Drug Topics
DECEMBER 3, 2024
The higher burden of neurological symptoms among younger and middle-aged adults translated to worse subjective quality of life, according to a recent study.
STAT
DECEMBER 3, 2024
Swedish pharmaceutical company Orexo will no longer pursue an app for treating depression after many years of struggling to sell it. Orexo announced this week that it will no longer license the product, called Deprexis, from German manufacturer GAIA. The companies have worked together on Deprexis in the United States since 2020 and have deals for two other apps, including Modia, an app that provides psychosocial support to people being treated for opioid addiction.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 3, 2024
Women with prepregnancy overweight or obesity may be more likely to experience postpartum depression.
STAT
DECEMBER 3, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Pharma vs Congress: The latest in telehealth talks Eli Lilly and Pfizer have responded to senators who pressed them to share the details of their online platforms LillyDirect and PfizerForAll , seeking to determine whether the pharma giants are violating the federal anti-kick
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
DECEMBER 3, 2024
On the most recent episode of Over the Counter, Steve Callahan, Senior Director of Advisory & Insights at MMIT, talked with us about biosimilars and the Inflation Reduction Act.
STAT
DECEMBER 3, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Lots on the table today about AI-driven drug discovery, including some startups to watch in this space. Also, we’ve updated our obesity drug tracker and we talk about Gilead’s new cancer deal.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 3, 2024
Postural orthostatic tachycardia syndrome (POTS) diagnoses have greatly increased following the COVID-19 pandemic.
Drug Topics
DECEMBER 3, 2024
A study found that patients with obesity who were diagnosed with type 2 diabetes aged 50 or younger had the highest risk of dementia.
Pharmacy Times
DECEMBER 3, 2024
High-dose vitamin C, when combined with chemotherapy, has shown the potential to double the survival rate of patients with late-stage metastatic pancreatic cancer.
Drug Topics
DECEMBER 3, 2024
TaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, discussed her career journey and why pharmacists are so crucial to the interoperability of health care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
DECEMBER 3, 2024
After failing a mid-stage trial, the biotech shifted course and is now targeting females with the goal of proving gender can play a role in depression outcomes.
Pharmacy Times
DECEMBER 3, 2024
As use of injectable medications increases for diabetes and other indications, proper administration is crucial.
PharmaVoice
DECEMBER 3, 2024
The biopharma, now an arm of AstraZeneca, needs to build the plane while flying it to be first in rare diseases with no other option.
Pharmacy Times
DECEMBER 3, 2024
The authors recommend that longer assessments with lengthier interventions should be performed to assess potential benefits.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
DECEMBER 3, 2024
A change in ownership and what it means for our readers.
pharmaphorum
DECEMBER 3, 2024
The MHRA has reminded pharma companies that from 1st January all medicines sold in the UK will have to comply with new labelling requirements
Fierce Healthcare
DECEMBER 3, 2024
Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out drug discounts to hospitals. | Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out drug discounts to hospitals.
The Guardian - Pharmaceutical Industry
DECEMBER 3, 2024
Coroner says evidence suggests Thomas Kingston, who was married to Lady Gabriella, had a ‘lack of suicidal intent’ The son-in-law of Prince and Princess Michael of Kent killed himself after suffering adverse side-effects from antidepressants prescribed by a Buckingham Palace doctor, an inquest has found. Thomas Kingston, 45, whose marriage to Lady Gabriella at Windsor Castle in 2019 was attended by the late Queen, died from a self-inflicted wound, the senior coroner for Gloucestershire concluded
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 3, 2024
Promoting antimicrobial stewardship and providing patient education are examples of strategies to prevent antimicrobial resistance.
pharmaphorum
DECEMBER 3, 2024
Patients in England with a rare form of eye cancer will be able to access Kimmtrak, a TCR therapy from Immunocore, after NICE changes its position
Pharmacy Times
DECEMBER 3, 2024
E-cigarette manufacturers claim the products aid in smoking cessation for adults without the risk of adolescent usage.
Fierce Healthcare
DECEMBER 3, 2024
Humana's chief financial officer Susan Diamond will step down in January, the insurer announced Tuesday. | Susan Diamond will exit the CFO role after three years and a total of eighteen across different positions at Humana, according to the company.
pharmaphorum
DECEMBER 3, 2024
Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415m.
PioneerRx
DECEMBER 3, 2024
Your pharmacy is already a trusted healthcare resource in your community, but you don’t have to stop at prescriptions or vaccines. Expanding your pharmacy’s.
pharmaphorum
DECEMBER 3, 2024
Cytokinetics should hear back from the FDA next September about its application for Camzyos rival aficamten in obstructive hypertrophic cardiomyopathy
Pharmacy Times
DECEMBER 3, 2024
Investigators say basic immunodeficiency screening should be completed in full for this patient population.
Pharmaceutical Technology
DECEMBER 3, 2024
Olema Oncology and Novartis have signed a clinical trial collaboration and supply agreement for a Phase III trial in metastatic breast cancer.
pharmaphorum
DECEMBER 3, 2024
Ipsen has expanded its oncology pipeline by licensing a T cell engager (TCE) therapy from Paris-based startup Biomunex for up to $610m
Pharmaceutical Technology
DECEMBER 3, 2024
Many machines are required for pharmaceutical milling processes. Can you reduce that number, streamline operations and improve efficiency?
The Checkup by Singlecare
DECEMBER 3, 2024
Vyvanse is a popular prescription medication that is used to treat attention deficit hyperactivity disorder (ADHD). The drug is also approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe binge eating disorders. Headaches can be a side effect when taking this mental health medication. In clinical trials, 1% of participants who took Vyvanse experienced headaches.
Pharmacy Times
DECEMBER 3, 2024
If approved, the new indications include children 6 years and older with moderate to severe plaque psoriasis and children 5 years and older with active juvenile psoriatic arthritis.
Outsourcing Pharma
DECEMBER 3, 2024
Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028
Pharmacy Times
DECEMBER 3, 2024
The therapy has similar benefits for both older and younger patients with multiple myeloma.
Expert insights. Personalized for you.
531 
Let's personalize your content